2019
DOI: 10.1016/j.mpaic.2019.06.001
|View full text |Cite
|
Sign up to set email alerts
|

Non-opioid analgesics

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…Cannabinoids have been offi cially admitted among nonopioid analgesics. The current public opinion is moving toward more widespread acceptance of cannabinoids and physicians will increasingly be encountering the use of cannabinoids in their practice [31].…”
Section: Discussionmentioning
confidence: 99%
“…Cannabinoids have been offi cially admitted among nonopioid analgesics. The current public opinion is moving toward more widespread acceptance of cannabinoids and physicians will increasingly be encountering the use of cannabinoids in their practice [31].…”
Section: Discussionmentioning
confidence: 99%
“…Glucocorticoids, well-known for their powerful anti-inflammatory properties, are restricted for athletes due to their classification as doping substances in certain situations and their unfavorable side effect profile [8]. NSAIDs, unlike opioids, do not interfere with sensory perception or consciousness [9]. Opioids can induce pleasurable sensations and carry an additional risk of addiction due to withdrawal when terminating treatment.…”
Section: Introductionmentioning
confidence: 99%
“…Non-opioid analgesics are those drugs by which analgesia can be achieved without affecting opioid receptors. These include nonsteroidal anti-inflammatory drugs (NSAIDs), acetaminophen, anticonvulsants (inhibitors of voltage-gated sodium or calcium ion channels, e.g., phenytoin, lamotrigine, carbamazepine, gabapentinoids, levetiracetam), antidepressants including tricyclic antidepressants (TCAs) and selective serotonin reuptake inhibitors (SSRIs) (e.g., amitriptyline, nortriptyline, duloxetine, venlafaxine), TRPV1 antagonists (capsaicin), cannabinoids, and muscle relaxants (e.g., benzodiazepines) [1]. The World Health Organization (WHO) has introduced an analgesic ladder to determine the degree of pain and appropriate pharmacotherapy in cancer pain and acute and chronic painful non-cancer disorders.…”
Section: Introductionmentioning
confidence: 99%